QuiaPEG

Newsroom

Sept 18, 2019

QuiaPEG Pharmaceuticals Holding AB (publ) has received a so-called "Notice of Allowance" on the granting of patents in Canada.QuiaPEG Pharmaceuticals Holding AB (publ), which develops improved and patentable versions of clinically validated or already approved drugs using the company's unique technology platform, announces that the company has received a so-called “Notice of Allowance” from the Canadian Patent Office.

Download press release (PDF)
Contact
QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 54 Uppsala
Sweden
+46 (0) 70 693 12 53
info@quiapeg.com

User terms & privacy policy
Send a message